Pharmafile Logo
Pharmafocus logo
Advanced Search

ASCO

Showing 11 posts of 56 posts found.

Promising signs for Novartis’ lung cancer drug

June 4, 2013
Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis

Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …

News

Merck Serono staff may strike over Geneva HQ closure

June 6, 2012
Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

News
ASCO

Herceptin successor impresses at ASCO

June 6, 2012
Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …

News
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011
Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …

Feature
Roche

Roche impresses at ASCO with vemurafenib

June 6, 2011
Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …

News
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010
Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …

Feature

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010
Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …

News
Avastin packs

Avastin promising in ovarian cancer

June 7, 2010
Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …

News
ASCObag

ASCO cancer conference opens

June 4, 2010
Research and Development ASCO, Cancer, lenalidomide, rituximab

One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …

News

ASCO 2009: advance of the blockbusters

June 18, 2009
Sales and Marketing ASCO, Cancer

Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …

News

Don’t pick on medicines in health service downturn, says ABPI’s Barker

June 18, 2009
Research and Development ASCO, Cancer

The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …

News

Latest content

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023

AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial

September 22, 2023

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023